Related Experiment Video
Updated: Feb 14, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
A Review of Interleukin-1 in Heart Disease: Where Do We Stand Today?
1Department of Cardiology, Tel Aviv Sourasky Medical Center Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. yishays@tlvmc.gov.il.
Insights
Inflammation drives cardiovascular diseases. Blocking Interleukin-1 (IL-1), a key inflammatory molecule, shows promise for treating heart conditions and reducing mortality.
Area of Science:
- Cardiology
- Immunology
- Inflammation Research
Background:
- Cardiovascular diseases (CVDs) are a major global cause of death.
- Inflammation is increasingly recognized as central to CVD development.
- The Interleukin-1 (IL-1) family plays a critical role in inflammatory processes.
Purpose of the Study:
- To review the role of IL-1 in the pathogenesis of heart diseases.
- To explore the therapeutic potential of IL-1 blockade in cardiovascular medicine.
Main Methods:
- Review of recent scientific literature and clinical trials.
- Analysis of the inflammatory pathways involved in CVDs.
- Evaluation of Interleukin-1 blockade strategies.
Main Results:
- Accumulating evidence suggests IL-1 blockade is relevant for CVD treatment.
- IL-1 signaling contributes significantly to cardiovascular pathology.
- Targeting IL-1 presents a potential therapeutic avenue.
Conclusions:
- Interleukin-1 is a significant factor in cardiovascular disease.
- Therapeutic blockade of IL-1 warrants further investigation for CVD management.
- Targeting inflammation offers a promising strategy for cardiovascular health.
Abstract:
Cardiovascular diseases are the leading cause of death worldwide. Research in the last two decades has emphasized the inflammatory process as a key component in the pathogenesis of many of them. The Interleukin-1 family is a pivotal element of inflammation and has been well studied as a therapeutic target in various inflammatory states. Recent trials have explored the effect of Interleukin-1 blockade in cardiovascular diseases and initial evidence of the relevance of such treatment in this field of medicine accumulate. This review will describe the role of Interleukin-1 in heart diseases and the potential therapeutic effect of its blockade in such diseases.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Standing Waves
Rheumatic Heart Disease III: Medical Management

